Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,273,812 papers from all fields of science
Search
Sign In
Create Free Account
Thrombotic Microangiopathies
Known as:
Thrombotic Microangiopathies [Disease/Finding]
, Thrombotic microangiopathy
, Microangiopathy, Thrombotic
Expand
Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Blood Vessel
Glomerulonephritis sparse hair telangiectases
Hematopoietic and Lymphoid Cell
Hematopoietic and Lymphoid Tissue
Expand
Narrower (1)
Purpura, Thrombotic Thrombocytopenic
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. Klok
,
M. Kruip
,
+8 authors
H. Endeman
Thrombosis Research
2020
Corpus ID: 215551338
Highly Cited
2020
Highly Cited
2020
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
J. Helms
,
C. Tacquard
,
+15 authors
F. Meziani
Intensive Care Medicine
2020
Corpus ID: 216119392
Purpose Little evidence of increased thrombotic risk is available in COVID-19 patients. Our purpose was to assess thrombotic risk…
Expand
Highly Cited
2008
Highly Cited
2008
VEGF inhibition and renal thrombotic microangiopathy.
V. Eremina
,
J. A. Jefferson
,
+12 authors
S. Quaggin
New England Journal of Medicine
2008
Corpus ID: 205089366
The glomerular microvasculature is particularly susceptible to injury in thrombotic microangiopathy, but the mechanisms by which…
Expand
Highly Cited
2008
Highly Cited
2008
Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism
A. Torbicki
,
A. Perrier
,
+11 authors
J. Bassand
2008
Corpus ID: 205016477
Highly Cited
2007
Highly Cited
2007
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
S. Wiviott
,
E. Braunwald
,
+11 authors
E. Antman
New England Journal of Medicine
2007
Corpus ID: 15463361
BACKGROUND Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic…
Expand
Highly Cited
2005
Highly Cited
2005
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
I. Iakovou
,
T. Schmidt
,
+13 authors
A. Colombo
Journal of the American Medical Association (JAMA…
2005
Corpus ID: 43923060
CONTEXT Traditionally, stent thrombosis has been regarded as a complication of percutaneous coronary interventions during the…
Expand
Highly Cited
2002
Highly Cited
2002
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
S. Steinhubl
,
Peter B. Berger
,
+4 authors
E. J. Topol
Journal of the American Medical Association (JAMA…
2002
Corpus ID: 11067030
CONTEXT Following percutaneous coronary intervention (PCI), short-term clopidogrel therapy in addition to aspirin leads to…
Expand
Highly Cited
1996
Highly Cited
1996
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
D. Schultz
The Lancet
1996
Corpus ID: 24008127
Review
1996
Review
1996
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
P. Prandoni
,
A. Lensing
,
+7 authors
M. Prins
Annals of Internal Medicine
1996
Corpus ID: 28612901
Deep venous thrombosis of the lower extremity is a serious disorder; the estimated incidence is 1 per 1000 persons per year [1-3…
Expand
Highly Cited
1995
Highly Cited
1995
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
T. Warkentin
,
Mark Levine
,
+4 authors
J. Kelton
New England Journal of Medicine
1995
Corpus ID: 34208363
BACKGROUND Heparin-induced thrombocytopenia, defined by the presence of heparin-dependent IgG antibodies, typically occurs five…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE